Effects of vitamin E, vitamin C and polyphenols on the rate of blood pressure variation: Results of two randomised controlled trials

British Journal of Nutrition

Volumn 112, Issue 9, 2014, Pages 1551-1561

  Hodgson, Jonathan M ^a   Croft, Kevin D ^a   Woodman, Richard J ^b   Puddey, Ian B ^a   Bondonno, Catherine P ^a   Wu, Jason H Y ^a,c   Beilin, Lawrence J ^a   Lukoshkova, Elena V ^d   Head, Geoffrey A ^e   Ward, Natalie C ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Blood pressure variation; Polyphenols; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; PLACEBO; POLYPHENOL; TOCOPHEROL; ANTIOXIDANT;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; FOOD INTAKE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; VITAMIN BLOOD LEVEL; AGED; BLOOD PRESSURE; CHEMISTRY; DIET; DRUG EFFECTS; MIDDLE AGED; PLANT SEED; VITIS;

AGED; ALPHA-TOCOPHEROL; ANTIOXIDANTS; ASCORBIC ACID; BLOOD PRESSURE; DIET; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLACEBOS; POLYPHENOLS; SEEDS; TOCOPHEROLS; VITAMIN E; VITIS;

EID: 84908465812     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514002542     Document Type: Article

References (52)

1. Rothwell PM (2011) Does blood pressure variability modulate cardiovascular risk? Curr Hypertens Rep 13, 177-186.
2. Parati G (2005) Blood pressure variability: its measurement and significance in hypertension. J Hypertens Suppl 23, S19-S25.
3. Rothwell PM (2010) Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 375, 938-948.
4. Rothwell PM, Howard SC, Dolan E, et al. (2010) Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375, 895-905.
5. Manios E, Tsagalis G, Tsivgoulis G, et al. (2009) Time rate of blood pressure variation is associated with impaired renal function in hypertensive patients. J Hypertens 27, 2244-2248.
6. Zakopoulos NA, Tsivgoulis G, Barlas G, et al. (2005) Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension 45, 505-512.
7. Zakopoulos NA, Tsivgoulis G, Barlas G, et al. (2006) Impact of the time rate of blood pressure variation on left ventricular mass. J Hypertens 24, 2071-2077.
8. Eguchi K, Ishikawa J, Hoshide S, et al. (2009) Night time blood pressure variability is a strong predictor for cardiovascular events in patients with type 2 diabetes. Am J Hypertens 22, 46-51.
9. Muntner P, Shimbo D, Tonelli M, et al. (2011) The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 57, 160-166.
10. Ohkubo T (2007) Prognostic significance of variability in ambulatory and home blood pressure from the Ohasama study. J Epidemiol 17, 109-113.
11. Webb AJ, Fischer U, Mehta Z, et al. (2010) Effects of antihypertensive- drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 375, 906-915.
12. Zis P, Vemmos K, Spengos K, et al. (2013) Ambulatory blood pressure monitoring in acute stroke: pathophysiology of the time rate of blood pressure variation and association with the 1-year outcome. Blood Press Monit 18, 94-100.
13. Hodgson JM, Croft KD, Woodman RJ, et al. (2013) Black tea lowers the rate of blood pressure variation: a randomized controlled trial. Am J Clin Nutr 97, 943-950.
14. Kumar KV & Das UN (1993) Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 19, 59-66.
15. Gopaul NK, Manraj MD, Hebe A, et al. (2001) Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism. Diabetologia 44, 706-712.
16. Panza JA, Quyyumi AA, Brush JE, et al. (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323, 22-27.
17. Davi G, Ciabattoni G, Consoli A, et al. (1999) In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99, 224-229.
18. Huang HY, Appel LJ, Croft KD, et al. (2002) Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial. Am J Clin Nutr 76, 549-555.
19. O'Byrne DJ, Devaraj S, Grundy SM, et al. (2002) Comparison of the antioxidant effects of Concord grape juice flavonoids a-tocopherol on markers of oxidative stress in healthy adults. Am J Clin Nutr 76, 1367-1374.
20. Rimm EB, Stampfer MJ, Ascherio A, et al. (1993) Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328, 1450-1456.
21. Stampfer MJ, Hennekens CH, Manson JE, et al. (1993) Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328, 1444-1449.
22. Fletcher AE, Breeze E & Shetty PS (2003) Antioxidant vitamins and mortality in older persons: findings from the nutrition add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Am J Clin Nutr 78, 999-1010.
23. Mursu J, Nurmi T, Tuomainen TP, et al. (2008) Intake of flavonoids and risk of cancer in Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Cancer 123, 660-663.
24. Mursu J, Voutilainen S, Nurmi T, et al. (2008) Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr 100, 890-895.
25. Ward NC, Wu JH, Clarke MW, et al. (2007) The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J Hypertens 25, 227-234.
26. Miller ER 3rd, Pastor-Barriuso R, Dalal D, et al. (2005) Metaanalysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142, 37-46.
27. Ward NC, Hodgson JM, Croft KD, et al. (2005) The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebocontrolled trial. J Hypertens 23, 427-434.
28. Juraschek SP, Guallar E, Appel LJ, et al. (2012) Effects of vitamin C supplementation on blood pressure: a metaanalysis of randomized controlled trials. Am J Clin Nutr 95, 1079-1088.
29. Hodgson JM, Puddey IB, Woodman RJ, et al. (2012) Effects of black tea on blood pressure: a randomized controlled trial. Arch Intern Med 172, 186-188.
30. Perez-Vizcaino F, Duarte J, Jimenez R, et al. (2009) Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep 61, 67-75.
31. Curtis PJ, Potter J, Kroon PA, et al. (2013) Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial. Am J Clin Nutr 97, 936-942.
32. Ward NC, Croft KD, Puddey IB, et al. (2004) Supplementation with grape seed polyphenols results in increased urinary excretion of 3-hydroxyphenylpropionic acid, an important metabolite of proanthocyanidins in humans. J Agric Food Chem 52, 5545-5549.
33. Bilo G, Giglio A, Styczkiewicz K, et al. (2007) A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J Hypertens 25, 2058-2066.
34. Clarke MW, Ward NC, Wu JH, et al. (2006) Supplementation with mixed tocopherols increases serum and blood cell g-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes. Am J Clin Nutr 83, 95-102.
35. Kearney PM, Whelton M, Reynolds K, et al. (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365, 217-223.
36. Whelton SP, Chin A, Xin X, et al. (2002) Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 136, 493-503.
37. Kim SH, Lee YM, Jee SH, et al. (2003) Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials. Obes Res 11, 1116-1123.
38. Xin X, He J, Frontini MG, et al. (2001) Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 38, 1112-1117.
39. He FJ & MacGregor GA (2011) Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet 378, 380-382.
40. Appel LJ, Moore TJ, Obarzanek E, et al. (1997) A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 336, 1117-1124.
41. Beilin LJ, Rouse IL, Armstrong BK, et al. (1988) Vegetarian diet and blood pressure levels: incidental or causal association? Am J Clin Nutr 48, 806-810.
42. Egert S, Boesch-Saadatmandi C, Wolffram S, et al. (2010) Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J Nutr 140, 278-284.
43. Ras RT, Zock PL & Draijer R (2011) Tea consumption enhances endothelial-dependent vasodilation; a metaanalysis. PLoS ONE 6, e16974.
44. Loke WM, Hodgson JM, Proudfoot JM, et al. (2008) Pure dietary flavonoids quercetin and (2)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 88, 1018-1025.
45. Ashor AW, Lara J, Mathers JC, et al. (2014) Effect of vitamin C on endothelial function in health and disease: a systematic review and meta-analysis of randomised controlled trials. Atherosclerosis 235, 9-20.
46. Wu JH, Ward NC, Indrawan AP, et al. (2007) Effects of a-tocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes. Clin Chem 53, 511-519.
47. Cowpland C, Su GM, Murray M, et al. (2006) Effect of alcohol on cytochrome p450 arachidonic acid metabolism and blood pressure in rats and its modulation by red wine polyphenolics. Clin Exp Pharmacol Physiol 33, 183-188.
48. Desch S, Schmidt J, Kobler D, et al. (2010) Effect of cocoa products on blood pressure: systematic review and metaanalysis. Am J Hypertens 23, 97-103.
49. Egan BM, Laken MA, Donovan JL, et al. (2010) Does dark chocolate have a role in the prevention and management of hypertension?: commentary on the evidence. Hypertension 55, 1289-1295.
50. Beavers DP, Beavers KM, Miller M, et al. (2012) Exposure to isoflavone-containing soy products and endothelial function: a Bayesian meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 22, 182-191.
51. Taku K, Lin N, Cai D, et al. (2010) Effects of soy isoflavone extract supplements on blood pressure in adult humans: systematic review and meta-analysis of randomized placebo-controlled trials. J Hypertens 28, 1971-1982.
52. Hodgson JM & Croft KD (2010) Tea flavonoids and cardiovascular health. Mol Aspects Med 31, 495-502